849987

Paul R. Harmatz, M.D. — FEI 3004936676

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 2, 2013
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Oakland, CA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance